Skip to main content
UniHealth

Doctor search

Miles Garth Kotchevar, NP

Nurse Practitioner · Stanford

NPI 1114576774

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Office
1

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Miles Garth Kotchevar’s office at (650) 723-4000 to ask if they take your plan before you enroll.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$9,600

Medicare paid this office $9,600 for 116 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
New patient visit (30+ min)52$4,595$88
Short return visit (20+ min)16$1,136$71
Return visit (30+ min)11$820$75

Who their Medicare patients are

116 Original Medicare patients in 2024. Average age 74 · Also on Medicaid 20% · Health risk score 0.92. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.

Conditions among them: Cancer 75% · High blood pressure 59% · Depression 22% · Diabetes 20% · Coronary heart disease 17% · Atrial fibrillation 11% · Chronic kidney disease 10%.

The office billed $64,411, Medicare allowed $12,786 and paid $9,600; for 122 services of 9 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024116122740.92$64,411$9,600
20236175701.34$31,542$5,811
20227189701.65$29,700$6,063
20211930741.38$13,757$2,560

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 3 services

Original Medicare services billed in 2023
Return visit (30+ min)30$2,226$70
Long return visit (40+ min)12$1,695$113
Short return visit (20+ min)13$622$48

2022: 3 services

Original Medicare services billed in 2022
Return visit (30+ min)33$2,748$74
Long return visit (40+ min)11$1,159$105
Short return visit (20+ min)15$724$45

Drugs they prescribed that Part D paid

$311,912

Pharmacies billed $311,912 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

81 generic and 30 brand-name prescriptions · $311,912 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Ibrance14$202,047$14,432
Anastrozole25$1,193$48
Letrozole13$287$22

Year by year

Part D prescribing by year
202411144None27%$311,912
20231866010% (18)23%$488,826
20222118412% (25)None$190,342
202111053None11%$119,586
20203719NoneNone$19,040

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 4 drugs

Part D drugs prescribed in 2023
Verzenio22$276,985$12,590
Anastrozole33$1,807$55
Letrozole15$907$60
Gabapentin11$116$11

2022: 3 drugs

Part D drugs prescribed in 2022
Anastrozole55$1,669$30
Tamoxifen Citrate16$649$41
Lorazepam18$58$3

2021: 3 drugs

Part D drugs prescribed in 2021
Anastrozole29$939$32
Tamoxifen Citrate15$738$49
Letrozole15$423$28

Money from drug and device companies

$355 in 2025

Industry payments by year
2025311None$355
202423None$191
202322None$58
202233$290$340

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
AstraZeneca Pharmaceuticals LPEnhertu$154
3 payments
  • Meals for Enhertu · 2025-12-17 · $17
  • Meals for Enhertu · 2025-12-16 · $21
  • Meals for Enhertu · 2025-11-11 · $115
AxogenNone$113
1 payment
  • Meals · 2025-07-24 · $113
Merck Sharp & DohmeKeytruda$89
4 payments
  • Meals for Keytruda · 2025-10-17 · $19
  • Meals for Keytruda · 2025-08-22 · $18
  • Meals for Keytruda · 2025-05-16 · $20
  • Meals for Keytruda · 2025-03-28 · $32
See all 8 published payments
Every published payment
AstraZeneca Pharmaceuticals LPMeals · 2025-12-17Enhertu$17
AstraZeneca Pharmaceuticals LPMeals · 2025-12-16Enhertu$21
AstraZeneca Pharmaceuticals LPMeals · 2025-11-11Enhertu$115
Merck Sharp & DohmeMeals · 2025-10-17Keytruda$19
Merck Sharp & DohmeMeals · 2025-08-22Keytruda$18
AxogenMeals · 2025-07-24None$113
Merck Sharp & DohmeMeals · 2025-05-16Keytruda$20
Merck Sharp & DohmeMeals · 2025-03-28Keytruda$32
See earlier years (2024, 2023, 2022)

2024: $191

Payments by company in 2024
Tactile Systems TechnologyFlexitouch Plus$130
1 payment
  • Meals for Flexitouch Plus · 2024-11-20 · $130
Merck Sharp & DohmeLynparza$61
2 payments
  • Meals for Lynparza · 2024-12-20 · $34
  • Meals for Lynparza · 2024-01-31 · $27

2023: $58

Payments by company in 2023
Merck Sharp & DohmeKeytruda$33
1 payment
  • Meals for Keytruda · 2023-10-18 · $33
PfizerIbrance$25
1 payment
  • Education for Ibrance · 2023-08-03 · $25

2022: $340

Payments by company in 2022
Gilead SciencesNone$290
1 payment
  • Consulting · 2022-08-23 · $290
GlaxoSmithKlineZejula$27
1 payment
  • Meals for Zejula · 2022-02-09 · $27
AstraZeneca Pharmaceuticals LPEnhertu$24
1 payment
  • Meals for Enhertu · 2022-12-14 · $24

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1114576774
Licence
CA 95011978
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Nurse practitioner (363L00000X); Federal specialty code 363LA2200X (363LA2200X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2019-09-06
NPI last updated
2025-12-30
NPI record certified
2025-12-30

This is when the NPI record was last certified, not a medical board exam.

This office lists an electronic records connection.